We have three topics for you today: We talk about our recent paper on the use of second-line immunotherapy in kidney cancer, the controversy over whether a cancer clinical trial was unethical, and the results of the randomized clinical trial CASSIOPEIA. 

Kidney Cancer: doi.org/10.1001/jamanetworkopen.2021.24728
CASSIOPEIA doi.org/10.1016/S1470-2045(21)00428-9

Back us on Patreon! www.patreon.com/plenarysession

Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew

4.26 Recent Kidney Cancer Trials, Unethical Cancer Clinical Trial, & CASSIOPEIA

A podcast on medicine, oncology, & health policy. 
Host: Vinay Prasad, MD MPH from University of California San Francisco.
Tweet your feedback to @Plenary_Session or e-mail plenarysessionpodcast@gmail.com

Science & Medicine

Natural Sciences

Social Sciences

Medicine

Asco Prequel - We talk about what to look for

Should trials have carbon footprint as an endpoint?

A SM crossover - Cifu, Prasad, Mandrola

My grand rounds; Beta blockers post MI
Single center vs multicenter RCT
Masks
Boosters and more

When Evidence EXPIRES - My Grand Rounds Today at Mt Sinai

I crossover SM podcast; Harvard med students video, Justice curriculum, Masking half the year

Cifu, Mandrola, Prasad - SM crossover

Patient advocates, Pharma funding, and is MRD a suitable endpoint

4.26 Recent Kidney Cancer Trials, Unethical Cancer Clinical Trial, & CASSIOPEIA

Download our free app to listen on your phone